Literature DB >> 21703556

Renal calcification in very low birth weight infants.

Hung-Yang Chang1, Chyong-Hsin Hsu, Jeng-Daw Tsai, Sung-Tse Li, Han-Yang Hung, Hsin-An Kao, Jui-Hsing Chang, Hsueh-Yu Chung, Hsin-Kai Wang.   

Abstract

BACKGROUND: Renal calcification in preterm infants has been described frequently. The etiologic factors have not yet been fully clarified. The objective of this study was to evaluate the incidence of and risk factors for renal calcification in our population.
METHODS: We retrospectively reviewed the charts of very low birth weight preterm infants during a 1-year period. Renal ultrasound scans were performed at term or before discharge and at a corrected age of 1 year.
RESULTS: Six infants (6%) had renal calcification at term or before discharge compared with 96 who did not. Factors significantly associated with renal calcification included gestational age (26 weeks vs. 29 weeks, p=0.006), birth weight (851 g vs. 1141 g, p=0.004), duration of mechanical ventilation (69 days vs. 29 days, p=0.002), length of intensive care (72 days vs. 41 days, p=0.013), furosemide therapy (33% vs. 3%, p=0.027), and dexamethasone therapy (50% vs. 2% p=0.001). Birth weight and dexamethasone therapy had significant independent association after stepwise logistic regression analysis. Sex, oliguria, acidosis, duration of oxygen therapy, length of hospital stay, nutrition status, and nephrotoxic drugs did not differ between the two groups. Three of the six infants had spontaneous remission of renal calcification, whereas two patients without the finding in neonatal stage had renal calcification at a corrected age of 1 year.
CONCLUSION: The incidence of renal calcification in very low birth weight infants in this study was relatively low, and the calcification was transient in one-half of the infants. Extremely premature, sick infants requiring long-term ventilation, and those receiving furosemide or dexamethasone were more likely to have renal calcification. Clinicians should be aware that renal calcification may develop beyond the neonatal stage.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703556     DOI: 10.1016/j.pedneo.2011.03.004

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  13 in total

1.  Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.

Authors:  Jeanne Fayard; Pierre Pradat; Sylvie Lorthois; Justine Bacchetta; Jean-Charles Picaud
Journal:  Pediatr Nephrol       Date:  2022-03-28       Impact factor: 3.651

Review 2.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

3.  Kidney stones: a fetal origins hypothesis.

Authors:  Sarah A Howles; Mark H Edwards; Cyrus Cooper; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

4.  Prevention of vitamin D deficiency in children following cardiac surgery: study protocol for a randomized controlled trial.

Authors:  J Dayre McNally; Katie O'Hearn; Margaret L Lawson; Gyaandeo Maharajh; Pavel Geier; Hope Weiler; Stephanie Redpath; Lauralyn McIntyre; Dean Fergusson; Kusum Menon
Journal:  Trials       Date:  2015-09-09       Impact factor: 2.279

5.  The effects of low and high dose oral calcium and phosphor supplementation on nephrocalcinosis diagnosed by sonography in premature and low birth weight neonates.

Authors:  Karmella Kamali; Narjes Pishva; Esmat Deireh
Journal:  Iran J Med Sci       Date:  2014-11

6.  Study protocol for a phase II dose evaluation randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study).

Authors:  Dayre McNally; Karin Amrein; Katharine O'Hearn; Dean Fergusson; Pavel Geier; Matt Henderson; Ali Khamessan; Margaret L Lawson; Lauralyn McIntyre; Stephanie Redpath; Hope A Weiler; Kusum Menon
Journal:  Pilot Feasibility Stud       Date:  2017-12-08

Review 7.  Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options.

Authors:  Alexander Weigert; Bernd Hoppe
Journal:  Front Pediatr       Date:  2018-04-12       Impact factor: 3.418

8.  Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis.

Authors:  Melissa J Schoelwer; Vidhya Viswanathan; Amy Wilson; Corina Nailescu; Erik A Imel
Journal:  J Endocr Soc       Date:  2017-08-01

Review 9.  Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.

Authors:  Wesley Jackson; Genevieve Taylor; David Selewski; P Brian Smith; Sue Tolleson-Rinehart; Matthew M Laughon
Journal:  Matern Health Neonatol Perinatol       Date:  2018-11-19

10.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.